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Abstract
The primary focus of classic cognitive behavioural therapy (CBT) for depression and anxiety is on decreasing symptoms 
of psychopathology. However, there is increasing recognition that it is also important to enhance wellbeing during therapy. 
This study investigates the extent to which classic CBT for anxiety and depression leads to symptom relief versus wellbeing 
enhancement, analysing routine outcomes in patients receiving CBT in high intensity Improving Access to Psychologi-
cal Therapy (IAPT) Services in the UK. At intake, there were marked symptoms of anxiety and depression (a majority of 
participants scoring in the severe range) and deficits in wellbeing (a majority of participants classified as languishing, rela-
tive to general population normative data). CBT was more effective at reducing symptoms of anxiety and depression than 
repairing wellbeing. As a result, at the end of treatment, a greater proportion of participants met recovery criteria for anxiety 
and depression than had moved from languishing into average or flourishing levels of wellbeing. Given the importance of 
wellbeing to client definitions of recovery, the present results suggest a greater emphasis should be placed on enhancing 
wellbeing in classic CBT.
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Anxiety and depressive disorders are prevalent, recurrent, 
frequently comorbid mental health conditions that are a sig-
nificant cause of worldwide disability (WHO 2017; Kessler 
et al. 2005, 2007). Psychological therapies for depression 
and anxiety predominantly focus on decreasing symptoms 
of psychopathology, conceptually underpinned by disease 
models arguing that recovery from mental illness equates 
to an absence of symptoms. Recovery is defined as falling 
beneath a cut-off on symptom measures, which moves indi-
viduals from a ‘clinical’ range to a ‘normal’ range.
When asking patients what recovery involves, a different 
perspective is increasingly emerging. A key component of 
recovery is the capacity to experience increased wellbeing, 
which can be defined as experiencing positive emotional 
states, feeling connected to and valued by others, and having 
a sense of meaning and purpose in life (Keyes 2002, 2005). 
Wellbeing enhancement is at least as important a part of 
recovery to patients as relief from symptoms (Zimmerman 
et al. 2006; Demyttenaere et al. 2015) and predicts future 
resilience (Garland et al. 2010; Wood and Joseph 2010). 
This perspective resonates with the broader recovery move-
ment arguing that recovery means individuals living a val-
ued and enjoyable life and minimising the extent to which 
symptoms impede this goal (Slade 2010).
There are different conceptual views as to how distinct 
wellbeing and symptoms are from one another. A single 
continua model sees symptoms and wellbeing as two oppo-
site ends of a bipolar dimension. Recovery involves moving 
individuals from the symptomatic end of the distribution 
and as far as possible into the wellbeing end of the distri-
bution (Huppert 2014). An alternative perspective is that 
symptoms and wellbeing represent orthogonal dimensions 
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(the dual-continua model: Tudor 1996; Provencher and 
Keyes 2011), based on findings that the two constructs are 
only moderately correlated in some samples and are best 
accounted for as two latent dimensions rather than a single 
latent dimension (Keyes 2005, 2006, 2007). Irrespective of 
which of these positions is adopted, treatment for anxiety 
and depression should aim to move individuals from a posi-
tion of ‘languishing’ (low wellbeing, high mental illness) 
to one of ‘flourishing’ (high wellbeing, low mental illness) 
(Keyes and Lopez 2002; Coulombe et al. 2016). Moreover, 
regardless of which of these frameworks is correct, it is 
likely that different intervention strategies will be required 
to develop wellbeing as opposed to reduce symptoms.
One of the most robustly validated and extensively 
deployed treatment modalities for anxiety and depression is 
cognitive therapy (CT), in UK contexts more often referred 
to as cognitive behavioural therapy (CBT). Classic CBT 
approaches focus on correcting negative biases in informa-
tion processing and avoidant behaviour in an effort to reduce 
symptoms of depression and anxiety (e.g. Beck et al. 1979; 
Clark and Beck 2010).1 There is good evidence that classic 
CBT is effective (although not optimally so) in reducing 
depression symptoms during acute episodes and to some 
extent minimising the risk of subsequent relapse (Cuijpers 
et al. 2013). Similarly, there is evidence of acute and sus-
tained benefit for CBT protocols for specific anxiety disor-
ders, but nevertheless with a subset of clients not responding 
or showing a chronic, relapsing course (Hofmann and Smits 
2008; Ali et al. 2017). This mirrors effective, but neverthe-
less sub-optimal, outcomes observed following other psy-
chological and pharmacological treatment modalities for 
anxiety and depression. Moreover, recovery rates in routine 
practice may be substantially lower than those observed in 
clinical trials (Lambert 2017).
Given the disease model underpinning classic CBT, it 
may well be better at reducing symptoms of mental illness 
than building wellbeing and adaptations are likely required 
to existing treatments to maximise wellbeing gains. In par-
ticular, symptom relief could be a necessary but not suffi-
cient component for enhancement of wellbeing. To optimise 
wellbeing, treatment may require symptom relief and also 
systematic attention to improving day-to-day positive mood, 
functioning, broader quality of life, and social connection/
identity. However, very few classic CBT trials have reported 
wellbeing outcomes, so the relative efficacy of the approach 
in repairing symptoms relative to wellbeing is yet to be 
definitively established.
We are aware of a handful of studies that indirectly exam-
ine the extent to which classic CBT repairs symptoms rela-
tive to wellbeing. These all used CBT as a control condition 
in small scale randomised controlled trials evaluating novel 
positive psychotherapies. One trial evaluated the efficacy of 
group CBT, relative to a group positive psychology inter-
vention, in treating acute depression and dysthymia using 
a broad array of symptom and wellbeing measures (Chaves 
et al. 2017). Pre-post effect sizes in CBT were larger for 
clinical variables (including depression; Cohen’s d = 0.44) 
than for positive functioning variables (including wellbe-
ing; Cohen’s d = 0.26). Three other studies did not report 
pre-post effect sizes for both wellbeing and symptoms, but 
we calculated these using the means and standard deviations 
described in the papers. We report Hedges g, as this is appro-
priate for smaller sample sizes.2 Fava et al. (1998a) rand-
omized 20 individuals with residual symptoms of affective 
disorder to receive 8 sessions of either group CBT or group 
wellbeing therapy. Individuals in the CBT arm showed large 
improvements on interviewer-rated depression (g = 1.35) 
and reported small improvements on self-rated wellbeing 
(g = 0.36). Fava et al. (2005) randomized 16 individuals with 
acute generalized anxiety disorder to receive either 8 ses-
sions of CBT or 8 sessions of CBT combined with wellbeing 
therapy. In the CBT only arm, there were large improve-
ment in interviewer rated depression (g = 0.96) and anxiety 
(g = 1.86) but only medium improvements in self-reported 
wellbeing (g = 0.52). Geschwind et al. (2019) allocated 40 
acutely depressed participants to receive a combination of 
individual CBT and a novel positive form of CBT (CBT +) 
in different orders, using a cross-over randomized controlled 
trial design. It is possible to isolate the pre-post effects in the 
20 depressed participants who were randomized to CBT fol-
lowed by CBT + , by focusing solely on observed change in 
the first treatment block only. After the first 8 CBT sessions, 
these participants showed a large effect size improvement in 
depression symptoms (g = 1.01) and a medium effect size 
improvement in wellbeing (g = 0.67).
This pattern of findings suggests that CBT is more 
effective at repairing symptoms than wellbeing. However, 
this conclusion is undermined by a number of methodo-
logical issues. None of these studies directly compared the 
1 Over the past forty years cognitive protocols have evolved and pro-
liferated. CBT can therefore be broadly defined as a family of inter-
ventions that aim to change how an individual thinks and behaves in 
an effort to repair mood. We are restricting our analysis to ‘classic’ 
Beckian protocols. By this we mean ‘second wave’ treatments that 
combine behavioural and cognitive approaches to modify negatively 
biased cognitive content in anxiety and depression. We distinguish 
these from more recent ‘third wave’ cognitive protocols that change 
the relationship to as well as the content of cognition. These ‘third 
wave approaches include Acceptance and Commitment Therapy, Dia-
lectical Behaviour Therapy, and Mindfulness Based Cognitive Ther-
apy. CBT protocols have also recently been adapted to have a more 
explicit recovery focus.
2 In these studies, the pre-post correlation for each measure was 
never described, so we assumed in all cases it was 0.5.
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magnitude of symptom versus wellbeing repair. As all of 
the studies had relatively small sample sizes, there are wide 
confidence intervals around the effect sizes reported above. 
Some of the studies used interviewer scales to assess symp-
toms and self-report scales to assess wellbeing, which may 
influence the size of the effects observed.
There is also a parallel body of work looking at how well 
CBT enhances quality of life (QoL), which has significant 
overlap with wellbeing as a concept. A recent meta-analysis 
examined the impact of classic CBT and drug treatment for 
depression on symptom and QoL measures in 37 randomised 
controlled trials (Hofmann et al. 2017). This found a large 
pre-post effect on depression severity (g = 1.30; 95% CI 
1.16–1.45). In contrast, there were only medium effects on 
QoL (g = 0.69; 95% CI 0.61–0.78). However, while QoL has 
clear overlap with wellbeing as a construct, it is not directly 
analogous (Salvador-Carulla et al. 2014). In particular, many 
QoL measures have a relatively narrow health/disease focus 
rather than a more holistic wellbeing focus, and so may miss 
broader benefits of treatment (e.g. see Al-Janabi et al. 2012).
Therefore, it is not possible to conclude to what extent 
classic CBT repairs wellbeing relative to symptoms on the 
basis of the extant literature and further research is needed. 
One efficient way to achieve this goal is to look at outcomes 
in routine clinical practice. The Improving Access to Psy-
chological Therapy (IAPT) initiative in the UK presents a 
good way to achieve this, as high volumes of patients are 
given protocol adherent classic CBT for depression and anx-
iety and routine outcome data are collected. IAPT services 
run a stepped care model, where mild to moderate presen-
tations are first treated with low intensity evidence-based 
approaches (for example, brief guided self-help) and are only 
‘stepped up’ to higher intensity interventions like individual 
CBT if they fail to respond. Individuals with a more com-
plex, recurrent or severe presentation can be offered high 
intensity as a first line treatment. Therefore, high intensity 
waiting lists are characterised by more severe, complex, 
and often treatment resistant presentations of depression 
and anxiety.
While wellbeing measures are not a standard part of the 
national IAPT outcome data set, they have been included 
as an additional outcome measure in some services. In par-
ticular, Somerset Partnership Foundation Trust (SPFT) sup-
plemented the minimum IAPT data set  with a wellbeing 
measure (the Warwick Edinburgh Mental Wellbeing Scale; 
WEMWBS, Tennant et al. 2007) between 2012 and 2017. 
The present study analyses wellbeing relative to symptom 
outcomes in this service, focusing on those individuals allo-
cated to high intensity CBT treatment for either depression 
or anxiety (typically between 8 and 20 sessions of individual 
therapy). The primary aims are: (i) to evaluate to what extent 
‘high intensity’ CBT repairs symptoms versus wellbeing; 
and (ii) to assess the extent to which wellbeing and symptom 
deficits are ‘normalised’ by the end of treatment.
Some thought is required about how to operationalise 
change and recovery on wellbeing measures. When using 
symptom-focused measures, the objective is to eliminate 
symptoms and to ensure individuals fall under some cut-off 
that indicates recovery. For example, the depression outcome 
measure used in IAPT is the Patient Health Questionnaire 
(PHQ-9; Kroenke et al. 2001) and scoring nine or less is 
used to indicate remission. It is less clear cut what indicates 
sufficient repair of wellbeing. One approach is to examine 
where a patient falls in the general population distribution 
before and after treatment using large scale normative data. 
The WEMWBS has been well validated on the UK general 
population, with data collected on over 7000 individuals as 
part of the UK Health of the Nation Survey. Therefore, it is 
possible to express WEMWBS scores for individual IAPT 
clients in terms of where they sit in this general popula-
tion distribution. Individuals scoring in the bottom third of 
the distribution can be viewed as ‘languishing’ and those 
scoring in the top third of the distribution can be viewed 
as ‘flourishing’. Recovery can be defined as scoring in 
the average or flourishing parts of the general population 
distribution.
We predict that CBT will lead to a greater magnitude 
repair of symptoms than wellbeing (Hypothesis One) and 
that at the end of treatment more individuals will meet 
recovery criteria for symptoms than wellbeing (Hypothesis 
Two). We will additionally explore to what extent wellbe-
ing and symptom measures are associated with one another 
and whether the extent of wellbeing and symptom repair is 
related to number of sessions attended. We had no a priori 
hypotheses for these exploratory analyses.
Method
Participants
Routine outcome data were collected on individuals being 
treated with high intensity CBT for depression and/or anxiety 
in the Somerset IAPT service between 2012 and 2017. Inclu-
sion criteria for the IAPT service were being over 18 years 
of age and presenting with a primary problem of depression 
or anxiety that met IAPT clinical criteria at the point they 
were put on the waiting list (PHQ-9 > 10 or GAD-7 > 8). A 
subset of individuals no longer met these caseness criteria 
at the point they started treatment. Following national IAPT 
guidelines, participants were not offered treatment if they 
presented with comorbid psychosis, bipolar disorder; if drug 
and alcohol misuse was the primary presenting problem; 
if there was a moderate to severe impairment of cognitive 
function; and if they presented with a high level of risk to 
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self or others that could not be safely managed in the service 
context. We extracted from the database the subset of data 
for clients who were allocated to high intensity CBT. South 
West Frenchay Health Research Authority granted ethical 
approval for the study (15/SW/0352, IRAS ID 163179). As 
patient data were anonymised and could not be linked back 
to individuals, patient consent was not required to access 
the data.
Measures and Procedure
The Warwick-Edinburgh Mental Wellbeing Scale (WEM-
WBS, Tennant et al. 2007) was used to measure wellbe-
ing. Participants rate to what extent they have felt the way 
described in 14 wellbeing statements (e.g. “I’ve been feeling 
optimistic about the future”) over the last 2 weeks, on a 
scale ranging from 1 (none of the time) to 5 (all of the time). 
Scores range from 14 (low wellbeing) to 70 (high wellbe-
ing). Normative WEMWBS data are available for 7020 indi-
viduals in the UK general population as part of the Health 
Survey for England 2011 (Mean = 51.61, SD = 8.71). As far 
as we are aware, there are no normative data for a depressed 
population. The WEMWBS has been found in previous stud-
ies to have good internal reliability (Cronbach’s α = 0.91) 
and acceptable one-week test–retest reliability (intraclass 
correlation = 0.83) (Tennant et al. 2007; Stewart-Brown et al. 
2009, 2011). In the present sample, internal reliability was 
also acceptable (intake α = .91). There are no agreed reliable 
or clinically significant change criteria for the WEMWBS.
The Patient Health Questionnaire (PHQ-9; Kroenke et al. 
2001) was used to measure depression symptom severity. 
Participants rate how many days over the past 2 weeks they 
have experienced the nine DSM-V symptoms of depression 
(e.g. “little interest or pleasure in doing things”), on a scale 
ranging from 0 (not at all) to 3 (nearly every day). Scores 
range from 0 (asymptomatic) to 27 (severely depressed), 
with scores of 5, 10, 15 and 20 representing mild, moder-
ate, moderately severe and severe depression respectively. 
A cut off score of 10 has been found to be a good proxy for 
meeting diagnostic criteria for a major depressive episode as 
measured by structured clinical interview, with 88% speci-
ficity and 88% sensitivity (Kroenke et al. 2010). This is also 
the cut-off used in UK IAPT services to indicate a clinical 
presentation. Normative data are available on 5018 individu-
als in the general population from face-to-face household 
surveys conducted in Germany between 2003 and 2008 
(Mean = 2.91, SD = 3.52) (Kocalevent et al. 2013). Studies 
find the PHQ-9 has good internal reliability (α = .89) and 
test–retest reliability (intraclass correlation = .84) (Kroenke 
et al. 2001). In the present sample, internal reliability was 
also acceptable (intake α = .85).
The Generalized Anxiety Disorder scale (GAD-7; Spitzer 
et al. 2006) was used to measure anxiety symptom severity. 
Participants rate how many days over the past 2 weeks they 
have experienced seven symptoms of anxiety (e.g. “feeling 
nervous, anxious, or on edge”), on a scale ranging from 0 
(not at all) to 3 (nearly every day). Scores range from zero 
(asymptomatic) to 21 (severely anxious), with scores of 5, 
10 and 15 representing mild, moderate and severe symp-
toms respectively. A cut off score of 10 was reported to have 
optimal sensitivity (89%) and specificity (82%) to confirm 
a diagnosis of generalized anxiety disorder based on struc-
tured clinical interview (although in UK IAPT services, a 
cut-off of ≥ 8 is used to indicate a clinically significant pres-
entation). Normative data are available on 5030 individu-
als in the general population from a nationally representa-
tive face-to-face household survey conducted in Germany 
(Löwe et al. 2008) (Mean = 2.95, SD = 3.41). The GAD-7 
has been found to have good internal reliability (α = .92) and 
test–retest reliability (intraclass correlation = .83) (Spitzer 
et al. 2006). In the present sample, internal reliability was 
also acceptable (intake α = .85).
The PHQ-9 and GAD-7 form part of the routine national 
data set administered prior to each session in IAPT, while 
the WEMWBS was only administered at first and last treat-
ment session.
Analysis Plan
All analyses used two-tailed tests with an alpha of .05. The 
proportion of individuals scoring above clinical cut-offs 
for anxiety and depression at each time point was reported 
(using standard IAPT criteria of PHQ-9 scores > 10 and 
GAD-7 scores > 8). We also describe the proportion of indi-
viduals who were languishing, showing average wellbeing, 
and flourishing (scoring in the bottom third [< 47], middle 
third [47–57], and top third [> 57] of the general population 
distribution respectively). We used these cut-offs to deter-
mine the proportion of individuals at each time point who 
fell into each category in the Provencher and Keyes (2011) 
model of complete mental health. This is a two (sympto-
matic, asymptomatic in terms of anxiety and depression 
symptoms) by three (languishing, averaging, flourishing in 
terms of wellbeing) affective space. To allow a direct com-
parison of recovery rates for symptoms versus wellbeing, 
we compared the proportion of participants at each assess-
ment point who met recovery criteria for symptoms (defined 
as scoring < 10 on the PHQ-9 and < 8 on the GAD-7) and 
wellbeing (defined as scoring in the average or flourishing 
part of general distribution; > 46) using McNemar tests for 
paired samples.
To analyse the extent of repair in each measure, we 
used two different analytic methods. If the same con-
clusions emerge across these different strategies, this 
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suggests they are likely to be robust. First, paired sample 
t-tests were run on pre- and post- scores. We reported 
Hedges g (and its 95% confidence interval) as a measure 
of effect size for each analysis. Second, the importance of 
tracking individual level as well as group level outcomes 
is increasingly realised (Guidi et al. 2018). Therefore, 
the proportion of individuals showing reliable improve-
ment and reliable deterioration on each measure from first 
to last session was calculated (cf. Jacobson and Truax 
1991). Reliable improvement/deterioration was defined 
as an improvement/deterioration of more than 1.96 times 
the standard error of difference for the scale. We used 
the standard deviation estimates from the present sample 
and estimates of test–retest reliability from scale valida-
tion studies in these analyses. The proportion of reliable 
improvement/deterioration on each measure was com-
pared using a series of pairwise McNemar tests.
Association between intake scores, change scores, and 
number of sessions were analysed using Pearson’s cor-
relation coefficients (reporting simple r and attenuation 
corrected r).
There was a relatively high degree of missing WEM-
WBS data at the final session assessment, so analyses 
were run on both a complete case basis and a multiple 
imputation basis (to simulate missing values). This is 
because there is ongoing debate in the literature about 
how best to analyse data were there is a relatively high 
proportion of missing data, where there is reason to think 
data may be ‘missing not at random’ (MNAR), and where 
there is a limited pool of auxiliary variables to use to pre-
dict missing values (Jakobsen et al. 2017; Madley-Dowd 
et al. 2019; van Ginkel et al. 2019). If an identical pattern 
of findings emerges with both analytic approaches, this 
suggests that the bias inherent in either method is unlikely 
to have substantially contaminated the results. Imputa-
tion was conducted using a Markov Chain Monte Carlo 
(MCMC) algorithm, with 70 imputation runs (based on 
guidance that the number of imputations should exceed 
the percentage of missing data; White et al. 2010). All 
variables used in subsequent analysis models (intake and 
final-session WEMWBS, PHQ-9, and GAD-7) as well as 
auxiliary variables that might predict variables with miss-
ing data were included in the imputation model. Auxiliary 
variables were age, gender, ethnicity, sessions attended, 
intake score on the IAPT phobia scale, intake score on 
the Work and Social Adjustment Scale (WSAS; Mundt 
et al. 2002), and intake score on the Standard Assess-
ment of Personality abbreviated scale (SAPAS; Moran 
et al. 2003). Multiple imputation analyses used pooled 
data across these 70 imputations. The imputed data set 
can be viewed as an intention-to-treat sample.
Results
Data Completeness
Intake WEMWBS, PHQ-9 and GAD-7 data were available 
for 1854 participants. Of these individuals, only 618 (39%) 
had final session data on all three measures. Complete case 
change and final session analyses were conducted on the 
subset of 618 individuals with complete data at final session; 
all other analyses were implemented on the entire sample.
Independent sample t-tests were run comparing intake 
demographic and clinical characteristics and symptom 
change score in individuals with and without complete data 
(see Table 1). At intake, there were small but nevertheless 
statistically significant differences between these groups. 
Those with complete WEMWBS data were significantly 
older, t(1596) = 2.45, p = .01; had significantly lower PHQ-9 
scores, t(1596) = 2,95, p < .001, had significantly higher 
WEMWBS scores, t(1596) = 3.29, p < .001, and tended to 
have lower GAD-7 scores at the level of a non-significant 
trend, t(1596) = 1.87, p = .06, compared to those without 
complete WEMWBS data. There were no significant gen-
der differences, χ2 < 1. There were significant and slightly 
greater magnitude differences in treatment responsiveness 
between the groups also. Those with complete WEMWBS 
data showed a greater improvement during treatment in 
PHQ-9 depression, t(1579) = 10.16, p < .001, and GAD-7 
anxiety, t(1579) = 9.70, p < .001, than those without com-
plete WEMWBS data. Those with complete WEMWBS 
data also attended a greater number of treatment sessions, 
t(1596) = 13.59, p < .001, than those without complete 
WEMWBS data. In summary, participants with WEMWBS 
data are a subgroup of individuals who are slightly older, 
less depressed and anxious at intake; attend more sessions; 
and are more treatment responsive.
Table 1  Demographic and clinical characteristics of individuals with 
and without post WEMWBS





Age 39.38 (13.8) 37.64 (13.7)
Gender 67% female 70% female
Session 1 PHQ-9 15.54 (6.07) 16.47 (6.13)
Session 1 GAD-7 14.03 (4.90) 14.51 (4.98)
Session 1 WEMWBS 33.80 (9.35) 32.23 (9.19)
Sessions completed 8.98 (3.47) 6.38 (3.87)
Δ PHQ-9 − 7.78 (6.20) − 4.57 (6.08)
Δ GAD-7 − 7.02 (5.73) − 4.19 (5.63)
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Wellbeing and Symptom Levels at Assessment
Table 2 reports intake and final session wellbeing, depres-
sion, and anxiety scores for participants (including both 
complete case and imputed estimates for final session 
data). The sample scored below the wellbeing general 
population levels (mean score of 33 compared to general 
population average of 51). 1707/1854 (92%) were classi-
fied as languishing; 125/1854 (7%) were classified as hav-
ing adequate mental health; and 22/1854 (1%) were clas-
sified as flourishing (8% in total meeting recovery criteria 
for WEMWBS). Similarly, the sample had elevated levels 
of depression and anxiety at intake. 1724 participants 
scored above IAPT cut-offs for either GAD-7 (> 8) or 
PHQ-9 (> 10), while 130 met symptom recovery criteria. 
622 participants (33%) were in the severe range for depres-
sion (PHQ-9 > 19) and 1020 participants (55%) were in the 
severe range for anxiety (GAD-7 > 14). The proportion of 
individuals meeting recovery criteria at intake did not sig-
nificantly differ for symptoms versus wellbeing, McNemar 
test p = .178.
Wellbeing and Symptom Change During High 
Intensity CBT
Paired sample t-tests showed a significant WEMWBS 
improvement (average increase of 10.94 points [SD = 10.99] 
for complete case data; average increase of 7.12 points 
[SD = 10.46] for imputed data), complete case paired-
sample t(617) = 24.75, p < .001, imputed paired-sample 
t(1853) = 23.926, p < .001. There was also a significant 
reduction in depression symptoms (mean drop of 7.78 points 
[SD = 6.20] for complete case data; mean drop of 5.26 points 
[SD = 6.25] for imputed data), complete case t(617) = 31.21, 
p < .001, imputed t(1853) = 36.07, p < .001. Similarly, there 
was a significant reduction in anxiety symptoms (mean drop 
of 7.02 points [SD = 5.73] for complete case data; mean drop 
of 4.77 points [SD = 5.79] for imputed data), complete case 
t(617) = 30.48, p < .001, imputed t(1853) = 35.38, p < .001. 
Figure 1 plots the effect size (and 95% confidence inter-
val) for change in each outcome measure for complete case 
data and imputed data. All effects were of a large magnitude 
(g > 0.8) for complete case data and of a large or medium 
effect size (g > 0.5 < 0.8) for imputed data according to rules 
of thumb (Cohen 1988). The anxiety and depression effects 
Table 2  Depression, anxiety and wellbeing at intake and final treat-
ment session (n = 618 with complete data, 1854 with imputed data)
Data are mean (SD) values




PHQ-9 15.54 (6.07) 7.76 (6.12) 10.96 (7.22)
GAD-7 14.03 (4.90) 7.00 (5.52) 9.57 (6.23)
WEMWBS 33.80 (9.35) 44.75 (10.91) 40.04 (11.93)
Fig. 1  Pre-post effect sizes for each measure on complete data (n = 618; a) and imputed data (n = 1854; b). Note: Data are mean (95% confidence 
interval) values
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sizes were numerically greater than the wellbeing effect size 
in both the complete case and the imputed analyses.
Reliable improvement was observed for 291 individuals 
(48%) for wellbeing, 339 individuals (55%) for depression 
and 364 individuals (59%) for anxiety in complete case anal-
yses. A greater proportion of individuals showed reliable 
improvement in depression relative to wellbeing, McNemar, 
p < .001, anxiety relative to wellbeing, McNemar p < .001, 
and anxiety relative to depression, McNemar p = .046. Reli-
able deterioration was observed for 9 individuals (1%) for 
the WEMWBS, 8 individuals (1%) for depression, and 4 
individuals (< 1%) for anxiety. There were no significant 
differences in the rates of deterioration for each outcome 
measure, McNemar ps > .266.
When using imputed data, reliable improvement was seen 
for 622.6 individuals (34%) for wellbeing, 727.1 individu-
als (39%) for depression, and 777.1 individuals (42%) for 
anxiety. More individuals improved for depression than 
wellbeing, McNemar p < .001, for anxiety than wellbeing, 
McNemar p < .001, and for anxiety than depression, McNe-
mar p = .013. Reliable deterioration was seen for 52.4 indi-
viduals (3%) for wellbeing, for 44.3 individuals (2%) for 
depression, and for 33.7 individuals (2%) for anxiety. There 
were no significant differences in the rates of deterioration 
for wellbeing and depression, McNemar p = .500, anxiety 
and depression, McNemar p = .206, or wellbeing and anxi-
ety, McNemar p = .066.
Wellbeing and Symptom Levels at Final Treatment 
Session
At the final treatment session, on average the sample contin-
ued to score below the wellbeing general population average 
(complete case mean score = 45; imputed mean score = 40). 
Using complete case data, 339 individuals (55%) were lan-
guishing, 191 individuals (31%) were in the average range, 
and only 88 individuals (14%) were flourishing. Using scor-
ing in the average or flourishing range as a proxy for recov-
ery, in total 44% had recovered on the WEMWBS. Using 
multiple imputation data, 1263.1 individuals (68%) were 
languishing, 429.6 individuals (23%) were in the average 
range, and 161.3 individuals (9%) were flourishing, with 
32% in total in recovery.
In terms of symptom outcomes, using complete case data 
242 individuals (40%) fell in the clinical range on one or 
both of the PHQ-9 and GAD-7, while the remaining 376 
individuals (60%) scored beneath caseness on both measures 
(the IAPT definition of recovery, Clark and Oates 2014) at 
the final treatment session. In total, 206 individuals failed 
to recover on either symptoms or wellbeing, 243 individuals 
recovered on both symptoms and wellbeing, 36 individuals 
recovered just on wellbeing, and 133 individuals recovered 
just on symptoms. A significantly greater proportion of 
individuals met recovery criteria for symptoms relative to 
wellbeing, McNemar p < .001.
Using imputed data, 1104.6 individuals (60%) fell in 
the clinical range on one or both symptom measures, while 
749.4 individuals (40%) scored beneath caseness (i.e. had 
recovered in IAPT terms) at the final treatment session. 
975.6 individuals failed to recover on either symptoms or 
wellbeing, 287.5 individuals recovered on symptoms but 
not wellbeing, 129.0 individuals recovered on wellbeing 
but not symptoms, and 461.9 individuals recovered on both 
symptoms and wellbeing. A greater proportion of individu-
als recovered for symptoms than wellbeing, McNemar test, 
p < .001.
Finally, we considered the percentage of participants 
falling in each space of the Provencher and Keyes model 
at final treatment session. Only 13% were in the optimal 
space of asymptomatic and flourishing (8% using imputed 
data). 26% were asymptomatic and had average wellbeing 
(17% using imputed data); 22% were asymptomatic and were 
languishing (15% using imputed data); < 1% were flourish-
ing but symptomatic (< 1% using imputed data); 5% were 
symptomatic and had average wellbeing (6% using imputed 
data); and 33% were symptomatic and languishing (53% 
using imputed data).3
Exploratory Association Analyses
Greater intake WEMWBS was significantly associated 
with lower depression (Pearsons’s r = − .645, p < .001; cor-
recting for attenuation r = − .739) and anxiety (r = − .515, 
p < .001; correcting for attenuation r = − .602). Greater anxi-
ety was also significantly associated with greater depres-
sion (r = .661, p < .001; correcting for attenuation r = .752). 
Greater increase in wellbeing over the course of treatment 
was significantly associated with a greater drop in depres-
sion (Pearson’s r on complete case data = − .604, p < .001, 
correcting for attenuation r = − .682, using imputed data 
3 The analyses comparing the magnitude of recovery for symptoms 
versus wellbeing are relying on essentially arbitrary definitions of 
recovery, particularly for the WEMWBS where no cut-off has yet 
been established. Another criteria that has been used in the literature 
is to define anyone who scores no more than one SD below the gen-
eral population average as being in recovery (which results in a lower 
cut-off score of 44 for the WEMWBS). Using this approach, at intake 
a greater proportion of individuals were in recovery for WEMWBS 
relative to symptoms, McNemar p<.001. At post-treatment, a greater 
proportion of individuals met recovery for symptoms relative to well-
being, McNemar, p=.002. We also conducted additional continu-
ous analyses on change on each measure in Z-score units (relative to 
general population averages) and proportion change units (relative to 
scale range). These continuous analyses do not rely on arbitrary cut-
offs to define recovery. These reached an identical conclusion to the 
categorical analyses, with greater repair of symptoms relative to well-
being (see supplementary materials for details).
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r = − .631, p < .001) and anxiety (complete case r = − .599, 
p < .001; correcting for attenuation r = − .671; imputed data 
r = − .613, p < .001). Greater depression repair was sig-
nificantly associated with greater anxiety repair (complete 
case r = .713, p < .001; correcting for attenuation r = .807; 
imputed data r = .749, p < .001). Attending more sessions 
was significantly linked to greater PHQ-9 repair (complete 
case r = − .130, p = .001; imputed data r = − .095, p < .001) 
and GAD-7 repair (complete case r = − .090, p = .025; 
imputed data r = − .095, p < .001) but was not significantly 
linked to wellbeing improvements (complete case r = .038, 
p = .344; imputed data r = .024, p = .440).
Discussion
This study investigated the extent to which routinely deliv-
ered classic CBT repairs symptoms versus enhances wellbe-
ing in a sample of individuals with anxiety and depression 
(using registry data from a high intensity UK IAPT service). 
At intake, there were marked deficits for both wellbeing and 
symptoms, with a vast majority of individuals showing clini-
cally significant levels of anxiety (GAD-7 > 7) or depres-
sion (PHQ-9 > 9) and languishing in wellbeing terms (falling 
in the bottom third of the general population distribution). 
Participants on average attended around 9 treatment ses-
sions and there was a significant increase in wellbeing and 
decrease in depression and anxiety symptoms between first 
and last treatment session.
Two different analytic techniques showed CBT had 
a larger effect on symptoms than wellbeing (supporting 
Hypothesis One). Pre-post effect sizes were numerically 
larger and a greater proportion of individuals showed reli-
able improvement of symptoms relative to wellbeing. While 
these two analytic methods both have their strengths and 
limitations, all reach the same conclusion. Unsurprisingly 
given the smaller magnitude of wellbeing relative to symp-
tom repair, at the final treatment session a smaller proportion 
of the sample met recovery criteria on the wellbeing (no 
longer falling in the languishing third of the general popula-
tion distribution) than met recovery criteria for symptoms 
(no longer showing clinically significant levels of depres-
sion and anxiety). Only a very small number of individuals 
were flourishing at the end of treatment. Therefore, Hypoth-
esis Two was also supported. The same pattern of results 
emerged in both complete case analyses and when using 
multiple imputation to simulate missing data. Overall out-
comes were superior in the complete-case analyses relative 
to the imputed data set on all variables (large versus medium 
pre-post effect sizes), but critically the relative magnitude 
of symptom versus wellbeing repair was the same in both 
sets of analyses.
This result broadly mirrors findings in previous trials 
that have included classic CBT as a comparator for novel 
positive psychology or wellbeing interventions (Chaves et al. 
2017; Geschwind et al. 2019; Fava et al. 1998a; Fava et al. 
2005) and also is consistent with meta-analytic findings that 
CBT and drug treatments for depression have a bigger effect 
on symptoms than quality of life (Hofmann et al. 2017). It 
extends them by directly comparing wellbeing and symptom 
deficits in a large clinical sample, giving greater precision to 
the estimates observed.
We also explored whether number of sessions predicted 
wellbeing and symptom repair. Attending a greater num-
ber of sessions attended was not significantly associated 
with wellbeing repair, despite being robustly associated 
with greater anxiety and depression repair. Therefore, it 
is unlikely to be sufficient to enhance wellbeing outcomes 
simply by offering a longer treatment dose of existing CBT 
protocols (although of course correlational data of this kind 
cannot be used to test causal claims).
Given the present results show CBT is less effective 
at building wellbeing than reducing depression (and that 
increasing number of sessions alone will not resolve this 
issue), it is important to consider alternative treatment 
approaches. One way forward is to adapt the delivery of clas-
sic CT so that it more explicitly addresses positive affect and 
wellbeing deficits (see Dunn, in press). This could include 
a greater focus on identifying values to help clients build 
meaning, more systematic targeting of underlying mecha-
nisms that block positive affect (e.g. dampening: Burr et al. 
2017; experiential processing; Gadeikis et al. 2017), and 
incorporation of a more explicit recovery focus (see Medalia 
et al. 2019).
A second way forward way could be to evaluate the 
potency of other established acute mood disorder treatments 
in repairing wellbeing, for example behavioural activation 
(BA; see Mazzucchelli et al. 2010). However, given there is 
significant content overlap between the activity scheduling 
aspects of CBT and BA protocols, it seems unlikely that 
BA will lead to significantly enhanced wellbeing outcomes 
relative to CBT. There may be greater potential in ‘third 
wave’ cognitive treatments like Acceptance and Commit-
ment Therapy (ACT; Hayes et al. 2012). However, what 
little evidence exists suggests that ACT may not optimally 
repair wellbeing. For example, a recent secondary analysis 
of an RCT found that a brief online version of ACT is also 
less effective at repairing wellbeing relative to symptoms 
(Trompetter et al. 2017).
A third approach could be to offer staged treatments, 
where classic CBT is used to treat symptoms and then a 
bespoke wellbeing therapy is offered afterwards as a sec-
ond step treatment (for example, Wellbeing Therapy; Fava 
2016). There is good clinical trial evidence that Wellbeing 
Therapy helps prevent relapse in depression (Fava et al. 
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1998b; Fava et al. 2004; Stangier et al. 2013), but wellbeing 
outcomes were not reported in these trials unfortunately. In 
two pilot trials that did include wellbeing measures, mixed 
results have emerged. Fava et al. (2005) showed superior 
wellbeing outcomes for Wellbeing Therapy relative to CBT 
in treating acute generalized anxiety disorder. The Wellbeing 
Therapy arm generated large effect size pre-post wellbeing 
improvement, whereas the CBT arm only led to small effect 
size improvement. However, Fava et al. (1998a) found no 
superiority of Wellbeing Therapy relative to CBT in treat-
ing residual affective disorders (small wellbeing pre-post 
effect sizes observed in each arm). Alternatives to Wellbeing 
Therapy as staging treatments are also starting to emerge. 
For example, Geschwind et al. (2019) demonstrate a large 
pre-post wellbeing effect size for CBT followed by a posi-
tive CBT protocol (albeit this wellbeing improvement was 
smaller than that observed for symptom relief).
Finally, novel acute therapies could be delivered that 
explicitly target wellbeing from the outset. Application of 
positive psychology approaches in clinical populations have 
had limited success in repairing wellbeing. For example, 
Chaves et al. (2017) found no significant difference between 
group CBT and a group positive psychology intervention 
for acute depression, with both producing small to medium 
pre-post effect sizes. However, other treatments are being 
developed to target positive valence system deficits that have 
encouraging preliminary results on positive affect and well-
being (e.g. Taylor et al. 2017; Positive Affect Treatment, 
Craske et al. 2019; Augmented Depression Therapy, Dunn 
et al. 2019). These novel therapies now require more robust 
evaluation in definitive trials in diagnosed depressed and 
anxious populations.
The findings also open opportunities for personalised 
approaches to care, whereby treatment selection could be 
tailored depending on the type of deficits the client presents 
with. For example, clients with particularly marked wellbe-
ing deficits may benefit from approaches explicitly targeting 
positive outcomes, whereas clients presenting with particu-
larly marked deficits in symptoms may benefit from existing 
approaches such as CBT. Emerging analytical techniques 
have the potential to match patients to the most effective 
treatments in this way (e.g. The Personalised Advantage 
Index; DeRubeis et al. 2014).
We provide an estimate of wellbeing deficits at intake as 
measured by WEMWBS in a real world clinical sample (a 
high intensity IAPT population). Our results suggest wellbe-
ing levels in this high intensity IAPT sample are over two 
standard deviations on average below general population 
averages. This may be useful for benchmarking purposes 
for future work (although see the caveats raised below about 
generalisability of the present sample).
The present data speak to the debate about whether well-
being and symptoms should be viewed as at two ends of 
a single dimension or as orthogonal constructs. Wellbeing 
showed a strong (but not perfect) negative association with 
anxiety and depression symptoms at intake, which became 
even stronger when correcting for attenuation. Similarly, 
there was a strong negative association between wellbe-
ing change and symptom change during treatment, which 
became more marked when attenuation was corrected for. 
This is more consistent with the single dimension account 
(Huppert 2014). This deviates from other studies showing 
that wellbeing and symptom repair are only weakly cor-
related (for example, Trompetter et al. 2017). It may be 
that this discrepancy in part reflects the choice of wellbe-
ing measure used. We deployed the WEMWBS to meas-
ure wellbeing, which has a  high degree of content overlap 
with symptom measures (particularly with the PHQ-9). The 
WEMWBS can be critiqued as simply a positively rather 
than negatively framed measure of the same underlying 
symptom features tapped by the PHQ-9. Bifactor analyses 
have not shown the WEMWBS to be distinct from symp-
tom measures in a large community sample (Böhnke and 
Croudace 2016). In contrast, Trompetter et al. (2017) used 
the Mental Health Continuum short-form, which may be 
a purer measure of wellbeing that is more distinct from 
psychopathology.
Even if wellbeing and symptoms are to some extent meas-
uring the same underlying construct, it is still beneficial to 
measure them separately. Goal setting theory argues objec-
tives are more likely to be achieved if they are couched in 
approach rather than avoidance terms (Elliot et al. 1997; 
Roskes et al. 2014). Reducing levels of depression and anxi-
ety is an avoidance goal, whereas enhancing levels of well-
being is an approach goal. Moreover, symptom measures 
may be relatively insensitive to the upper half of a single 
mental health continuum (measuring movement from nega-
tive to neutral mental health but not from neutral to positive 
mental health). It is noteworthy that of the individuals who 
met recovery criteria for symptoms, many were still lan-
guishing and very few were flourishing in wellbeing terms.
Limitations of the present study need to be held in mind. 
First, and most critically, there was a substantial degree of 
missing WEMWBS data at follow-up and these data were 
potentially ‘missing not at random’ (MNAR). Those with 
complete data were older, had less marked symptoms and 
higher wellbeing, were more treatment responsive, and 
attended more sessions. These differences may reflect cli-
ent willingness to fill in extra measures as a function of 
whether they felt they benefitted, therapist implicit biases 
in who they gave post-treatment WEMWBS to, or the fact 
that WEMWBS was only given at planned discharge (where 
response rates are likely to be superior). These character-
istics of the completer sample may be biasing results, in 
particular artificially inflating effect sizes on all outcome 
variables. Partially offsetting this concern, it is reassuring 
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that an identical pattern of findings emerged when analysing 
the imputed dataset (effectively an intention-to-treat sam-
ple). There is ongoing debate about the reliability of multiple 
imputation with a high degree of missing data, when the 
data may be MNAR and when only a limited set of auxiliary 
variables are available to predict missing values (van Ginkel 
et al. 2019; Jakobsen et al. 2017; Madley-Dowd et al. 2019). 
Nevertheless, multiple imputation may provide less biased 
results than list wise deletion when data are MNAR. Over-
all, while it is encouraging that the same pattern of findings 
(greater repair of symptoms relative to wellbeing) emerged 
in both complete-case and multiple imputation-based analy-
ses, neither method are free from bias when data are MNAR. 
Therefore, caution needs to be taken when generalising these 
findings to other samples.
Second, this is an uncontrolled study using routine reg-
istry data, meaning that factors such as spontaneous recov-
ery over time and treatment expectancy are not accounted 
for. Moreover, we only had the demographic and clinical 
information that is routinely collected in IAPT services 
(which is less extensive than that which is typically cap-
tured in research studies). This limits the extent to which 
detailed comparisons can be made to other research samples 
and also precluded moderation analyses being conducted. 
Future research should examine which baseline variables 
predict wellbeing repair during CBT. Third, the sample is 
also not entirely representative of IAPT services, as it was 
part of a personality disorder demonstration site rather than 
routine IAPT care. This meant that the service had latitude 
to take on clients with a greater degree of comorbid person-
ality pathology than is typically deemed eligible for IAPT 
and also had more flexibility about the number of sessions 
they could offer to clients. This should be taken into account 
when using this data to estimate how well high intensity 
CBT in more routine IAPT settings will perform in repair-
ing wellbeing (given that previous work suggests those with 
more marked personality disorder features do less well in 
IAPT generally; Goddard et al. 2015).
Fourth, it is important to recognise that the pattern of 
results regarding magnitude of change of wellbeing versus 
symptoms do not necessarily generalise beyond the specific 
measures used (the PHQ-9, GAD-7, and WEMWBS). It may 
simply be the case that the measures are differentially sensi-
tive to change, with the PHQ-9 and GAD-7 being more sen-
sitive than the WEMWBS. The findings require replication 
using a broader array of outcome measures. Fifth, the sam-
ple was selected on the basis of scoring above cut-offs on the 
PHQ-9 and GAD-7, reflecting standard practice in IAPT set-
tings. While these scores have been shown to predict diag-
nostic status with a reasonable degree of accuracy, it would 
have been methodologically stronger to have diagnostically 
interviewed participants. Sixth, greater repair of symptoms 
relative to wellbeing could simply reflect regression to the 
mean, in that the sample was further away from the general 
population average scores for symptoms than wellbeing at 
intake. Seventh, definitions of positive recovery focus on 
optimising functioning (i.e. being able to perform in key 
life areas like vocation, family, relationships, and hobbies) 
as well as wellbeing. We did not consider functioning out-
comes here. Eighth, reflecting the way in which the GAD-7 
is used in IAPT services, we are equating changes in this 
scale with changes in overall anxiety. However, the GAD-7 
was originally designed as a screening tool and severity indi-
cator for generalized anxiety disorder specifically rather than 
anxiety more broadly. Finally, we did not have accurate data 
on the use of psychotropic medications, so possible interac-
tions between drug and psychological therapy could not be 
examined.
In conclusion, notwithstanding the above caveats, our 
findings suggest that classic CBT does a better job of repair-
ing symptoms than building wellbeing. There is a need to 
enhance existing treatments, and potentially to develop novel 
treatments, that better target wellbeing enhancement in addi-
tion to symptom relief.
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